EORTC

Skip to Main Content Area

EORTC Melanoma Group investigating use of PEG-IFN- α-2b for patients with stage II ulcerated primary cutaneous melanoma

EORTC Lung Cancer Group studying potential new indication for pazopanib for patients with non-small cell lung cancer

Are we ready for new models of Academia–Industry Partnerships?

Colorectal Cancer Biomarker Screening Platform

rss

HIGHLIGHTS

EORTC Launches Brain Metastasis Platform

ASCO 2012 report places four EORTC studies among those with greatest potential impact on patients’ lives

Transgene Collaborates with EORTC on Phase 2b Trial with TG4001 in Head & Neck Cancer

EORTC Research Fellow wins New Investigator award at 2012 ISOQOL Conference

SAVE THE DATE

rss

Markers in Cancer: A joint meeting by ASCO, EORTC & NCI

EORTC-EANO-ESMO: Trends in Central Nervous System Malignancies

22 March 2013 - 23 March 2013

Clinical Trial Statistics For Non Statisticians (Brussels, Belgium)

11 June 2013 - 14 June 2013

Joint ECCO-AACR-EORTC-ESMO Workshop on Methods in clinical cancer research

22 June 2013 - 28 June 2013

rss

RESEARCH UPDATE

New EORTC studies activated in 2012

EORTC academic study shows how whole brain radiotherapy affects health-related quality of life in patients with brain tumors

EORTC study emphasizes value of patient-reported symptoms

Bacillus Calmette Guérin in the treatment of patients with non-muscle invasive bladder cancer: what dose and duration of treatment?

The primary intent of this website is the communication of clinical cancer research with oncologists and health professionals in the field, but it is recognized that the information presented here might also be of interest to patients, charities, funding organizations and the general public.
        Disclaimer
  
HOW TO REACH USAvenue Mounier, 83/11
1200 Brussels
Belgium
Directions & Accomodations
+32 2 774 16 11
eortc [ at ] eortc.be
Youtube channel
Contact form
        CAREER OPPORTUNITIES  
We are always looking for new talents. Please find hereunder the current positions open at EORTC HQ in Brussels.
Current openings
 This site complies with the HONcode standard for trustworthy health information: verify here.
SPECIAL THANKSEORTC is partially supported by the Belgian National Lottery and by the Belgian Federal Science Policy Office.
Funding
    Last website update:     20 March 2013  

      Home
Sitemap
EORTC Intranet
UP
    

Investigator's Area

HIGHLIGHTS

SAVE THE DATE

RESEARCH UPDATE

HOW TO REACH US

CAREER OPPORTUNITIES

SPECIAL THANKS